Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Orexo AB et al v. Actavis Elizabeth LLC et al
Case Number:
1:17-cv-00205
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 12, 2019
Orexo Loses Bid For New Trial Over Teva's Suboxone Generic
A Delaware federal judge won't give Orexo AB another chance to prove that a Teva unit's generic version of the opioid addiction treatment drug Suboxone infringes a patent covering its own drug Zubsolv.
-
March 29, 2019
Del. Jury Clears Teva In $41M Orexo Drug Patent Suit
A Teva Pharmaceuticals Ltd. subsidiary did not infringe Orexo AB's opioid addiction treatment drug Zubsolv with two generic drugs, a Delaware federal jury ruled Friday, after a five-day trial over Orexo's infringement case that sought at least $41 million in damages.